The objective of this retrospective analysis was to describe the development and implementation of an anesthesiologist-led multidisciplinary committee to evaluate high-risk surgical patients in order to improve surgical appropriateness. The study was conducted in an anesthesia preoperative evaluation clinic at an academic comprehensive cancer center. One hundred sixty-seven high-risk surgical patients with cancer-related diagnoses were evaluated and discussed at a High-Risk Committee (HRC) meeting to determine surgical appropriateness and optimize perioperative care. The HRC is an anesthesiologist-led model for multidisciplinary review of high-risk patients developed at Roswell Park Comprehensive Cancer Center. The group of high-risk patients in which surgery was not performed had, on average, a greater percentage of hypertension, smoking history, dyspnea, heart failure, chronic obstructive pulmonary disease, diabetes, renal failure, and sleep apnea than the group in whom surgery was performed. Only one of 107 high-risk patients who had surgery died within the first 30 days after surgery. A smaller percentage of patients died in the group that had surgery versus the group in which surgery was canceled. For all patients discussed by the HRC, the mortality was less than 2% within the first 30 days after the HRC.
A multidisciplinary approach to surgical care among members of the health care team before surgery may be especially important for complex or "high-risk" patients with multiple comorbidities having invasive and complicated procedures. Recent studies have shown that a significant number of surgical procedures are being performed in the last year of a patient's life as well as procedures being performed during a terminal admission. [10] [11] [12] With finite health care resources and the emphasis on increasing the value of surgical care and the patient's quality of life after surgery, all members of the perioperative team must take an active role in facilitating appropriate surgical care. The preoperative anesthesia evaluation is an opportunity or "pause point" to evaluate the patient beyond the primary indication for surgery and assess the appropriateness of proceeding with surgery. 13 Uncontrolled comorbidities and changes in the patient's goals and preferences that may alter the treatment plan can all be explored during the preoperative anesthesia evaluation. Despite the best intentions of the health care team, many patients have deficits in surgical decision making that may also need to be addressed. 14, 15 The concept of a multidisciplinary meeting to reach a consensus on optimal care has been described for many diseases. A "tumor board" is well established in cancer care. 16, 17 The discussion at these meetings is usually centered specifically on a particular cancer diagnosis and therapeutic options available to the patient, not just surgical ones. Review of surgical cases is typically done at the department level among fellow surgeons with certain consultants (ie, radiologists) and focuses on surgery-specific considerations (ie, the surgical technique) rather than a broader perspective of the patient. 18, 19 There is increasing interest to foster more collaboration in surgical care, especially for high-risk patients; however, this approach will require a cultural shift and a commitment by all team members to share accountability for outcomes of surgical or nonsurgical care. 20 The Royal College of Anesthetists has proposed a multidisciplinary approach to surgical care in the perioperative period. Meetings should be facilitated to make a collaborative decision as to whether or not to operate, to optimize the patient preoperatively, and to outline the multidisciplinary care needed intra-and postoperatively. 21 Anesthesiologists, especially those involved in all facets of perioperative care, from preoperative evaluation through the surgery and postoperative critical care and pain management, are uniquely positioned to facilitate collaboration for appropriate surgical care in a multidisciplinary format. Anesthesiologists may be able to offer insight and expertise on how the patient's comorbidities may affect the surgical approach, outcomes, and quality of life after surgery.
To date, however, no group or institution has been able to develop and execute a model for multidisciplinary surgical shared decision making that asks not only whether the correct surgery will be performed but also whether surgery is the best option for high-risk patients. In the area of cancer surgery, there exists a wide variation in postoperative complications and mortality at institutions throughout the United States that indicate areas for improvement. 22 We hypothesize that a multidisciplinary committee that discusses and evaluates high-risk surgical patients, led by an anesthesiologist, in an open and collegial environment is feasible to implement at a comprehensive cancer center. Our model, called a High-Risk Committee (HRC), serves as a starting point and template from which to move forward the concept of defining appropriateness in surgical care. It is a tool to mitigate risk and anticipate complications and challenges for the patient throughout the perioperative period prior to surgical intervention.
M AT E R I A L S A N D M E T H O D S
We obtained institutional review board approval for our retrospective study prior to analyzing the data. The design of our study was to retrospectively review demographic and case-specific information for the 167 patients that were discussed at the hospital's HRC from the spring of 2014 to spring 2017. This is a prospectively maintained data set. The two main groups of patients that we investigated were (1) patients who had surgery and (2) patients who did not have surgery after the HRC. While our study was neither powered nor designed to detect a statistical difference between the groups, we were able to analyze the rates of postoperative outcomes and mortality. Every patient discussed at our HRC during this period was included in the data analysis. Data were collected and analyzed by the authors, with input from other HRC participants. The electronic health record as well as documentation and e-mails created after the HRC meetings were reviewed.
Identifying and evaluating "high-risk" patients
Roswell Park is an academic, comprehensive cancer center located in Buffalo, New York, that specializes in the diagnosis and care of patients with different types of cancer. The Anesthesia Perioperative Evaluation Clinic (APEC) at Roswell Park evaluates the vast majority of surgical patients prior to the proposed procedure either in person or by telephone interview. APEC is directed by an anesthesiologist, who staffs the clinic each day with the assistance of midlevel providers, anesthesia resident rotators, and support staff. Like many anesthesia preoperative clinics, the goal is to optimize patients prior to the day of the procedure to increase operating room efficiency and patient satisfaction, reduce unnecessary tests and consultations, decrease length of stay in the hospital, and decrease day-of-surgery cancellations. [23] [24] [25] [26] [27] In our clinic, we hypothesized that we could go further in our risk assessment and patient stratification in collaboration with our surgical and medical colleagues to improve the quality of the surgical care we provide. As part of the routine evaluation and preparation of patients before surgery, patients may be identified as high-risk. The designation of high-risk may be applied for a variety of reasons, including the invasiveness of the surgery, the patient's underlying comorbidities, or concern about the intraoperative or postoperative course and recovery of the patient. Any member of the perioperative team (ie, APEC anesthesiologist, surgeon, or consultant) may deem a patient high-risk.
Our policy is that consideration be given to cases deemed high-risk by objective measures. Patients with advanced systemic disease (especially poorly controlled disease), patients of advanced age and/or with limited functional capacity, patients with deficits in surgical decision making or with social support issues, and patients in whom surgical risk may outweigh potential benefit may all be designated as high-risk. At APEC, we adhere to the recommendations of the 2014 American College of Cardiology/American Heart Association Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. 28 We utilize the self-reporting of functional capacity using the Duke Activity Status Index calculator to determine the patient's measurement of exercise tolerance before surgery (METS). 29 We have developed internal guidelines for the routine ordering of preoperative laboratory testing to minimize waste and unnecessary orders based on the surgery type and the patient's comorbidities. We also measure frailty using a published scale 30 for patients over age 65. The American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) risk calculator is commonly employed by APEC staff as the screening tool of choice. 31 We use the ACS-NSQIP calculator only for American Society of Anesthesiologists Physical Status (ASA PS) 3 or higher. A calculated risk of death or postoperative complications that is two times over the expected rate will trigger consideration for high-risk status along with elevated risk of postoperative complications and need for rehabilitation. A METS of less than 4 usually triggers further workup or investigation but does not necessitate a high-risk designation. Criteria for requesting a review for a high-risk patient are intentionally nonspecific and liberal to encourage open discussion among members of the health care team with respect to what is ultimately best for the patient. Figure 1 is a flowchart depicting the patient selection process as well as the HRC format.
A thorough and complete preanesthetic evaluation and optimization for high-risk patients is performed as with all patients seen at APEC. A full history and physical examination are complemented with necessary medical consultations, laboratory testing, and collection of relevant outside documentation. Patients identified as high-risk are then referred to an HRC for further discussion.
The HRC format
The HRC at Roswell Park Comprehensive Cancer Center was formed in the spring of 2014. Since that time, more than 167 patients have been evaluated by the HRC. The HRC is coordinated and administered by the APEC anesthesiologist, with the full support of the Center's administration. An HRC meeting is organized by one of the department administrators, and invitations are sent out to the relevant parties via a scheduling e-mail. The HRC is held near the surgical suites to facilitate clinician attendance. Meetings are held on an ad hoc basis at a standardized time. The scheduling is flexible, depending on the needs of the participants and urgency of the proposed procedure. Participants are given a summary of the case and supporting documentation prior to the meeting to review.
The HRC is composed of the following members:
• Surgeon specific to the case • Medical director of APEC or delegate
• Chair of surgical oncology or delegate, if available
• Anesthesiologist who evaluated the patient at APEC or who will be assigned to the case
• Critical care physician
• Palliative care
• Ethics officer
• Consultants as indicated (cardiologist, pulmonologist, medical oncologist, etc)
In order to facilitate efficient discussion, the meeting format has been standardized. Members of the committee are sent the preoperative assessment along with any relevant supporting clinical data prior to the meeting for review. The HRC meeting begins with a brief case review by the surgeon, which includes the patient's diagnosis, history of present illness, relevant comorbidities, prognosis with and without surgery, and surgical options and nonsurgical alternatives with their associated prognoses. Additional pertinent information is then provided by the anesthesia team or consultants. ACS-NSQIP risk calculator information and frailty scores are included whenever possible. The patient's wishes for surgery and recovery are also brought up for consideration, based on discussions members of the health care team have had with the patient or the patient's caregivers.
Once all of the relevant information has been presented, a thorough risk-benefit discussion ensues, with the goal of answering the question, "Is this case risk prohibitive?" In other words, while this patient may have a surgical indication for the proposed procedure, is the surgery appropriate with respect to a broader appreciation of the patient's risk factors and goals of treatment? In all cases, a group consensus is reached.
There are three possible outcomes to the HRC:
• The case is not risk prohibitive and the case can proceed as planned
• The case is not risk prohibitive but optimization is required before the surgery can be performed such as prehabilitation or additional testing
• The case is risk prohibitive and is cancelled If the case is deemed risk prohibitive, the surgery is canceled. The HRC may make recommendations on alternative nonsurgical options such as chemotherapy, radiation therapy, or palliative care. In some situations, the HRC may prescribe a series of steps that patients can take in order to improve their health status and decrease their perioperative risk to acceptable levels. Some patients have been reconsidered for surgery.
If the case is deemed to be "not risk prohibitive," the discussion moves toward optimizing the patient's situation prior to surgery. This may include:
• Perioperative medication adjustment such as anticoagulation, cardiac medications, and so on
• Inclusion in our Enhanced Recovery After Surgery (ERAS) pathways, as indicated
• Prehabilitation (ie, preoperative physical therapy, pulmonary optimization, nutritional support, etc)
• Obtaining advance directives or health care proxy documentation
• Recommendations regarding the procedure itself (eg, open vs minimally invasive, downgrading to a lesser procedure)
• Recommendations regarding anesthetic management and technique (eg, general vs regional anesthesia, special precautions, fluid management, ventilation strategies, postoperative pain control)
• Recommended intraoperative access and monitoring
• Preemptive planning for possible case-specific untoward scenarios or complications
• Postoperative disposition (eg, discharge home vs general surgical floor vs intermediate care unit vs intensive care unit)
• Postoperative monitoring
• Postoperative consults as needed HRC meeting lengths vary in time; however, they are usually completed within 15 to 30 minutes. After the meeting, the medical director of APEC or delegate communicates the HRC findings to all involved parties. A summary of the discussion as well as all relevant recommendations are documented in the electronic health record. A notation is made on the electronic anesthesia preoperative evaluation note along with a concise summary of recommendations. A second notation is also added to the daily operating room schedule stating that the patient's case was presented at the HRC. This mechanism reminds all who might be involved in the patient's care to review the electronic medical record note or the group e-mail.
The patient is notified of any important decisions of the HRC (eg, case delayed or canceled) by the surgeon or the APEC team if there is a requirement for follow-up testing or prehabilitation.
R E S U LT S
Qualitative and quantitative data on HRC patients Table 1 presents sample vignettes of patients that have been evaluated by the HRC. Table 2 shows the demographic information, comorbidities, and primary surgical service for HRC patients who had surgery and those for whom surgery was not performed. While our data were neither powered nor designed to detect a statistical difference between groups, the data are presented to describe our patient population and how the patient population at other institutions may compare to ours.
Several trends emerge after reviewing the HRC data set. There was a relatively even distribution of patients in several age categories from under 65 through 85 and over, which would suggest that age was not an absolute -Surgery is preferred therapy but not urgent and pt would benefit from optimization.
-Recommend sustained medication compliance, complete smoking cessation and 6 weeks of pulmonary rehabilitation followed by pulmonology re-evaluation.
-If able to demonstrate significant improvement in her pulmonary function patient will be reconsidered for the OR.
-8 months later FEV 1 33% with improved functional capacity.
-Reconvened HRC suggests minimally invasive procedure.
-Surgery performed with uncomplicated 5 day postop course.
52yo woman with muscle invasive bladder cancer for robotic cystectomy with anterior pelvic exoneration.
PMHx: moyamoya disease with recent CVA now status-post ECIC bypass, recent NSTEMI due to hematuria while on dual antiplatelet therapy, DM, chronic pain and seizure disorder.
-Cystectomy is treatment of choice. Repeat bout of significant hematuria may be life threatening. Not risk prohibitive if patient agrees with proceeding at elevated risk.
-Neurosurgery, cardiology and surgeon agree with proceeding on ASA 81mg, strict hemodynamic goals and intraoperative neuromonitoring.
-ICU, intraoperative monitoring and analgesic plan discussed.
-Advanced directives and proxy prior to OR.
-Advanced directives completed.
-Pt to OR with uneventful intraoperative course.
-Discharged home in stable condition on postoperative day 10.
80yo male with 2 nd recurrence of invasive SCC of the oropharynx with pharyngocutaneous fistula scheduled for pharyngo-esophagectomy, left carotid endarterectomy, gastric pullup and reconstruction (2 day procedure). PMHx: SCCs status-post laryngectomy and radiation, HTN, CAD, aortic stenosis and a history of TIAs.
-Risk-benefit ratio discussion highlighted that the procedure was unlikely to be curative, only palliative to aid with secretions and tolerating oral diet.
-Significant risks included (among other things) a very high possibility of perioperative CVA and death.
-Given advanced age and multiple comorbidities, recommendation made to not proceed with surgery.
-Referred to palliative care for symptom control.
-Procedure cancelled.
-Patient referred to palliative care.
ASA, aspirin; CA, cancer; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; ECIC, external carotid/internal carotid; FEV 1 , forced exhalation volume; HTN, hypertension; ICU, intensive care unit; OR, operating room; PMHx, past medical history; SCC, squamous cell carcinoma; TIA, transient ischemia attack.
contraindication for HRC evaluation. The group of patients in whom surgery was not performed had, on average, a greater percentage of hypertension, smoking history, dyspnea, heart failure, chronic obstructive pulmonary disease, diabetes, renal failure, and sleep apnea than those in whom surgery was performed. The surgical services with the most HRC patients reviewed were gastrointestinal surgery and endocrine surgery. Table 3 shows the outcome data for HRC patients who had surgery and for those who did not. Only one of 107 HRC patients who had surgery died within the first 30 days after surgery. A smaller percentage of patients died in the group that had surgery versus the group in which surgery was canceled. For all patients discussed by the HRC, the mortality was less than 2% within the first 30 days after the HRC. COPD, chronic obstructive pulmonary disease.
D I S C U S S I O N
We believe our novel model for multidisciplinary discussion of high-risk patients led by anesthesiologists along with surgical and medical specialists, risk managers, and ethicists offers an improvement in the evaluation and clearance of high-risk patients for surgical procedures. The template for forming an HRC that we have developed may be adopted and used in many different clinical settings. The key for successful implementation is active communication among members of the health care team, especially between surgeons and anesthesiologists. Every member of the patient's health care team should have the ability to send a case to the HRC for review. Support from administration with respect to the decisions made by the HRC is also vital.
There are several factors that make the HRC at our center advantageous. The surgical and anesthesia departments at Roswell Park are relatively small and focused on the specific disease process of cancer. This may foster familiarity among staff and lead to better baseline communication. Other institutions with different surgical cases, volumes, or patient populations may need to modify our template or start with one surgical specialty as a pilot program. Nonetheless, the model we propose is adaptable when the members of the health care team participate.
There are several challenges to implementing our model. Some surgeons may have been trained or otherwise influenced to be the primary decision makers in the care of their patients. However, engaging in shared decision making requires a cultural shift within surgery. 19 To be effective, it should start on a department-by-department basis within a hospital. Trust must be established between surgeons and anesthesiologists. Fundamental assumptions must also be agreed upon. First, surgeons are not purposefully trying to perform "inappropriate" surgery. It is not always feasible for the surgical consultation to identify all aspects of the patient's complex history. 32 The preoperative anesthesia evaluation is an opportunity to further investigate these broader issues and intervene. 21 As we have seen, neither patient age, ASA PS class, nor comorbidity necessarily guarantees an HRC meeting. Important issues may evolve and reveal themselves between the surgical appointment and the day of surgery.
On the other side, surgeons have to trust that anesthesiologists are not just trying to "cancel the case" or be obstructionists when deeming a patient high-risk. The goal of the HRC is not to cancel cases or avoid doing complicated ones. In fact, the majority of cases that have been evaluated by the HRC have ended up being performed (107 vs 60). The goal is to optimize all modifiable risk factors and come to a consensus that the proposed surgery is the best option, weighing both the risks and benefits. The HRC does not eliminate risk, and complications are still expected. The utility of the HRC is to optimize the patient's situation as much as possible and anticipate potential issues that could arise. We also want to align the risks and benefits of the surgery with the patient's values and preferences for treatment. This includes medical considerations as well as social factors such as the patient's support group and resources that may impact recovery. Interestingly, at our institution, surgeons currently request more HRC meetings than anesthesia staff or medical consultants on average, signaling a change in how the HRC is viewed and utilized at our center. In a few instances, the surgeon believed that surgery was not the best treatment option for a patient; however, the patient was pushing for a surgical intervention. The HRC was a useful tool for the surgeon to discuss the case in a multidisciplinary format and report back to the patient the consensus that surgery was not in the patient's best interest. The cancellation rate for HRC has decreased over time including our most recent, unpublished data. Clinicians are using the HRC both as a tool to determine the appropriateness of surgery as well as a way to engage in ways to optimize the perioperative course for patients. The HRC model continues to be modifiable based on the needs of our center.
The challenging part of the HRC is to determine statistically if there is an outcome benefit to the HRC meeting. It is not ethical to randomize our patients to HRC versus no HRC. It is also difficult to propensity match our complex cohort of HRC patients with a similar group of patients. Each situation has unique characteristics such that compiling a critical number of patients with a similar presentation is not feasible. It is also difficult to compare the patients who had surgery with the patients who did not have surgery. The HRC can help the health care team determine which patients would benefit from surgery versus medical management alternatives. It is not possible to determine post hoc which was the right choice. Table 3 shows the outcome data for the group of patients that proceeded with surgery and the group of patients for whom surgery was deemed too high-risk. In each group, we recorded one patient death within the first 30 days after the HRC meeting. The utility of HRC meetings can be interpreted many ways, based on the particulars of a given institution. At our comprehensive cancer center, there is extrinsic pressure on APEC to evaluate and clear surgeries promptly due to the time-sensitive nature of cancer and risk for progression of disease. It is reassuring to us that the decision to either proceed or cancel surgery did not significantly alter mortality within the first 30 days after the meeting. In some situations, surgery is the best option for the patient, and in others the potential risks outweigh the benefits. We rely on our systematic process and thoughtful discussion of each individual patient to arrive at a reasonable decision that takes into account the patient's wishes and goals.
We believe there is intrinsic value in the HRC. By developing a formalized process to identify and discuss high-risk cases, we believe we are working toward the best interest of the patient. Since inception of the HRC, our ACS-NSQIP has improved. While we cannot claim a causal relationship, the administration at our center appreciates the value of having its clinicians actively engaged in communication to assess and mitigate risk, especially in the high-risk patient population.
The data we present are meant to offer other hospitals interested in this type of multidisciplinary approach a detailed perspective of our patients and the HRC process so that they can tailor our model to their specific needs. Patients are presenting with more comorbidities for surgery, 33 and the growing opinion of health care commentaries is that appropriateness of surgical care is important 34 and collaboration among members of the health care team may help ensure that appropriate surgical care is delivered. 19, 20 Despite our best intentions, some patients will have negative outcomes. We believe our model for addressing high-risk patients before planned surgery helps to identify the patients most at risk for negative outcomes and uses health care resources most effectively. There is certainly an investment of time and resources involved in establishing an HRC. We believe there is intrinsic value to patient safety with an HRC. We also have found anecdotally that the morale of clinicians is enhanced because we are performing less extraordinary care on patients not suited for major surgery. Also, the potential savings of avoiding only one or two unnecessary postoperative admissions with prolonged and complicated hospital courses predicted by exceedingly elevated ACS-NSQIP risk calculations may have major positive effects on an institution's bottom line. If we are to believe that HRCs are making a difference, the next question to address is the following: "Is it the recommendations and interventions of the HRC by way of preoperative, intraoperative, and postoperative care that account for this difference?" For example, does placement of an arterial line and use of advanced hemodynamic monitors improve care in our patients? Or is it the case that these patients usually end up on patient floors with increased monitoring and better nurse-to-patient ratios? Or is it that the act of convening and identifying a patient as "high-risk" somehow alters how health care providers approach them throughout the hospital course? The answer is likely multifactorial. The HRC is one part of a commitment to improve perioperative care by implementing evidence-based practices such as Enhanced Recovery After Surgery pathways 35 and goal-directed fluid therapy 36 as indicated. The HRC is only as useful as the collaboration it encourages among colleagues and the interventions used based on the best available evidence.
The anesthesiology department at our center has taken the lead in organizing and directing the HRC. In fact, we foresee the HRC being incorporated into different versions of the perioperative surgical home (PSH). The PSH is an evolving model of health care delivery in which anesthesiologists coordinate the perioperative care of the patient throughout the patient's hospital course. 37 The HRC could be an extension of the PSH because of the involvement of anesthesia in preoperative assessment and recommendations for operative and postoperative care.
In the future, we hope to continue to practice and modify our model further to improve patient involvement in the process for true surgical shared decision making. Enlisting the help of a patient advocate into the HRC meetings would be one step toward that goal. We also want to develop ways to standardize how we interpret patients' care wishes and assess their support system and resources, which may be implemented into the HRC meeting. It has been shown that patients have deficits in surgical decision making. 13, 14 The recommendations of the HRC may be a
